These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2146488)

  • 21. Slow calcium channel blockers and calmodulin. Effect of felodipine, nifedipine, prenylamine and bepridil on cardiac sarcolemmal calcium pumping ATPase.
    Lamers JM; Cysouw KJ; Verdouw PD
    Biochem Pharmacol; 1985 Nov; 34(21):3837-43. PubMed ID: 2933041
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CAPP-calmodulin: a potent competitive inhibitor of calmodulin actions.
    Newton DL; Klee CB
    FEBS Lett; 1984 Jan; 165(2):269-72. PubMed ID: 6319184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Importance of the interaction protein-protein of the CaM-PDE1A and CaM-MLCK complexes in the development of new anti-CaM drugs.
    González-Andrade M; Mata R; Madariaga-Mazón A; Rodríguez-Sotres R; Del Pozo-Yauner L; Sosa-Peinado A
    J Mol Recognit; 2013 Apr; 26(4):165-74. PubMed ID: 23456740
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chimeric calmodulin-cardiac troponin C proteins differentially activate calmodulin target enzymes.
    George SE; VanBerkum MF; Ono T; Cook R; Hanley RM; Putkey JA; Means AR
    J Biol Chem; 1990 Jun; 265(16):9228-35. PubMed ID: 2160966
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential regulation of Ca2+/calmodulin-dependent enzymes by plant calmodulin isoforms and free Ca2+ concentration.
    Lee SH; Johnson JD; Walsh MP; Van Lierop JE; Sutherland C; Xu A; Snedden WA; Kosk-Kosicka D; Fromm H; Narayanan N; Cho MJ
    Biochem J; 2000 Aug; 350 Pt 1(Pt 1):299-306. PubMed ID: 10926857
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of calmodulin stimulation of phosphodiesterase and Ca2+, Mg2+-ATPase activities and shape change of erythrocyte ghosts by chloroquine.
    Nagai F; Ushiyama K; Kano I; Nakagawa A; Nakao T; Nakajima A
    Biochem Pharmacol; 1987 Oct; 36(20):3433-7. PubMed ID: 2960325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of cyclic peptides and depsipeptides with calmodulin.
    Mereish KA; Solow R; Bunner DL; Fajer AB
    Pept Res; 1990; 3(5):233-7. PubMed ID: 1724618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo effects of cadmium on calmodulin and calmodulin regulated enzymes in rat brain.
    Vig PJ; Nath R
    Biochem Int; 1991 Mar; 23(5):927-34. PubMed ID: 1652964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic peptides based on the calmodulin-binding domain of myosin light chain kinase inhibit activation of other calmodulin-dependent enzymes.
    Blumenthal DK; Charbonneau H; Edelman AM; Hinds TR; Rosenberg GB; Storm DR; Vincenzi FF; Beavo JA; Krebs EG
    Biochem Biophys Res Commun; 1988 Oct; 156(2):860-5. PubMed ID: 2903735
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of calmodulin inhibitors on cyprid larvae of the barnacle, Balanus amphitrite.
    Yamamoto H; Tachibana A; Saikawa W; Nagano M; Matsumura K; Fusetani N
    J Exp Zool; 1998 Jan; 280(1):8-17. PubMed ID: 9437848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chlorpromazine and dimethyl sulfoxide modulate the catalytic activity of the plasma membrane Ca
    Plenge-Tellechea F; Domínguez-Solís CA; Díaz-Sánchez ÁG; Meléndez-Martínez D; Vargas-Medrano J; Sierra-Fonseca JA
    J Bioenerg Biomembr; 2018 Feb; 50(1):59-69. PubMed ID: 29313294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-protein interactions: isolation and characterization of covalent adducts of phenoxybenzamine and calmodulin.
    Lukas TJ; Marshak DR; Watterson DM
    Biochemistry; 1985 Jan; 24(1):151-7. PubMed ID: 3994963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of human platelet secretion and of Ca2+, calmodulin-dependent protein phosphorylation by the antiallergic agent GMCHA.
    Tanaka T; Saitoh M; Ito M; Shin T; Naka M; Endo K; Hidaka H
    Biochem Pharmacol; 1988 Jul; 37(13):2537-42. PubMed ID: 3390216
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid hormones inhibit the Ca2+ calmodulin-induced activation of myosin light chain kinase.
    Hagiwara M; Mamiya S; Ochiai M; Hidaka H
    Biochem Biophys Res Commun; 1988 Apr; 152(1):270-6. PubMed ID: 3358764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of calmodulin function by CV-159, a novel dihydropyridine compound.
    Umekawa H; Yamakawa K; Nunoki K; Taira N; Tanaka T; Hidaka H
    Biochem Pharmacol; 1988 Sep; 37(18):3377-81. PubMed ID: 2844186
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ca2+-dependent cyclic nucleotide phosphodiesterase is activated by poly(L-aspartic acid).
    Tanaka T; Ito M; Ohmura T; Hidaka H
    Biochemistry; 1985 Sep; 24(19):5281-4. PubMed ID: 3000429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cetiedil inhibition of calmodulin-stimulated enzyme activity.
    Levine SN; Berkowitz LR; Orringer EP
    Biochem Pharmacol; 1984 Feb; 33(4):581-4. PubMed ID: 6231031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preparation, characterization and biological properties of biotinylated derivatives of calmodulin.
    Polli JW; Billingsley ML
    Biochem J; 1991 May; 275 ( Pt 3)(Pt 3):733-43. PubMed ID: 1645521
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of myosin light chain kinase and nitric oxide synthase activities by calmodulin fragments.
    Persechini A; McMillan K; Leakey P
    J Biol Chem; 1994 Jun; 269(23):16148-54. PubMed ID: 7515878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differentiation of the drug-binding sites of calmodulin.
    Zimmer M; Hofmann F
    Eur J Biochem; 1987 Apr; 164(2):411-20. PubMed ID: 3032617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.